Cancer drug trial ends early after safety check
NCT ID NCT03770494
First seen Nov 05, 2025 · Last updated Jun 17, 2026 · Updated 38 times
Summary
This early-stage study tested a new drug called LY3405105 in 54 people with advanced solid tumors. The main goal was to check the drug's safety and find the right dose. The study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Columbia University Medical Center
New York, New York, 10032, United States
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Gustave Roussy
Villejuif, 94805, France
-
Highlands Oncology Group
Fayetteville, Arkansas, 72703, United States
-
Hospital Madrid Norte Sanchinarro
Madrid, 28050, Spain
-
Hospital Universitari Vall d'Hebron
Barcelona, 08035, Spain
-
Institut Bergonie
Bordeaux, 33076, France
-
Institut Curie
Paris, 75248, France
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
National Cheng-Kung Uni. Hosp.
Tainan, 704, Taiwan
-
National Taiwan University Hospital
Taipei, 10048, Taiwan
-
Princess Margaret Hospital
Toronto, Ontario, M5TY 2M9, Canada
-
Smilow Cancer Hospital at Yale-New Haven
New Haven, Connecticut, 06511, United States
-
Taichung Veterans General Hospital
Taichung, 40705, Taiwan
-
Taipei Veterans General Hospital
Taipei, 11217, Taiwan
-
University of Pennsylvania Hospital
Philadelphia, Pennsylvania, 19104, United States
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.